Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma;Recuperación ductular en el síndrome de los conductillos biliares evanescentes en paciente con linfoma de Hodgkin

Gastroenterologia y Hepatologia

Volumn 28, Issue 5, 2005, Pages 275-278

  Cordoba Iturriagagoitia A ^a   Inarrairaegui Bastarrica M ^a   Perez De Equiza E ^a   Zozaya Urmeneta, J M ^a   Martinez Penuela J M ^a   Beloqui Perez R ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; ERYTHROMYCIN; METHYLPREDNISOLONE;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE DUCT; BILE DUCT DISEASE; BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHOLESTASIS; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; JAUNDICE; MALE; POSTOPERATIVE PERIOD; REMISSION; TISSUE REGENERATION; VANISHING BILE DUCT SYNDROME;

EID: 18744413565     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074061     Document Type: Article

References (22)

1. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet. 1987;29:493-6.
2. Cervantes F, Briones J, Bruguera M, Font C, Grau JM, et al. Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. Ann Hematol. 1996;72:357-60.
3. Liangpunsakul S, Kwo P, Koukoulis GK. Hodgkin's disease presenting as cholestastic hepatitis with prominent ductal injury. Eur J Gastroenterol Hepatol. 2002;14:323-7.
4. Carneiro de Medeiros B, Lacerda MA, Queiroz JE, Santos da Silva JA, De Medeiros CR. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome. Haematol. 1998;83:1038-40.
5. Hubscher SG, Lumley MA, Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology. 1993;17:70-7.
6. Kömürcü S, Özet A, Altundag MK, Arpaci F, Öztürk, Celasun B, et al. Vanishing bile duct syndrome occuring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease. Ann Hematol. 2002;81:57-8.
7. Ripoll C, Carretero L, Sabin P, Álvarez E, Marrupe D, Bañares R. Colestasis idiopática asociada a ductopenia progresiva en dos pacientes con linfoma de Hodgkin. Gastroenterol Hepatol. 2002;25:313-5.
8. Martin KR, Moore TJ, Wright RA. Obstructive jaundice secondary to primary biliary involvement with Hodgkin's disease. Am J Gastroenterol. 1992;87:1194-5.
9. Allory Y, Metreau JM, Zafrani ES. Rarefaction para néoplasique des canaux biliaires interlobulaires au cours d'un cas de maladie de Hodgkin. Ann Pathol. 2000;20:52-5.
10. Lieberman DA. Intrahepatic cholestasis due to Hodgkin's disease: an elusive diagnosis. J Clin Gastroenterol. 1986;8:304-7.
11. Birrer MJ, Young RC. Differencial diagnosis of jaundice in lymphoma patients. Semin Liver Dis. 1987;3:269-77.
12. Ludwig J, Wiesner RH, La Russo NF. Idiopathic adulthood ductopenia. A cause of chronic cholestasis liver disease and biliary cirrhosis. J Hepatol. 1988;7:193-9.
13. Crosbie OM, Crown JP, Nolan NPM, Murray R, Hegarty JE. Resolution of paranoeoplastic bile duct paucity following successful treatment of Hodgkin's disease. Hepatology. 1997;26:5-8.
14. Pérez Calle JL, Salcedo M, Núñez O, Barrio J, Bañares R, De Diego A, et al. Ductopenia asociada a hepatitis por citomegalovirus en un paciente portador de trasplante cardíaco. Gastroenterol Hepatol. 2003;26:26-8.
15. Lefkowitch JH, Falkow S, Whitlock RT. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med. 1985;109:424-6.
16. Alam I, Ferrel LD, Bass NM. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol. 1996;91:1626-30.
17. De Galoscy C, Horsmans Y, Rahier J, Geubel AP. Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report. J Clin Gastroenterol. 1994;19:269-71.
18. Moradpour D, Altorfer J, Flury R, Greminger P, Meyenberger C, Jost R, et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology. 1994;20:1437-41.
19. Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol. 1994;89:1230-4.
20. Geubel AP, Nakad A, Rahier J. Prolonged cholestasis and disappearance of interlobular bile ducts following chorpropamide and erythromycin ethylsuccinate. Case of drug interaction? Liver. 1988;8:350-3.
21. Degott C, Feldmann G, Larrey D. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology. 1992;15:244-51.
22. Moreno A, Carreño V, Cano A, González C. Idiopathic biliary ductopenia in adults without symptoms of liver disease. N Engl J Med. 1997;336:835-8.